Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jemima Scott"'
Publikováno v:
Kidney International Reports, Vol 8, Iss 12, Pp 2814-2817 (2023)
Externí odkaz:
https://doaj.org/article/4b0b305d489d48f0b0826d781e87d9d1
Autor:
Jemima Scott, Patrick Bidulka, Dominic M. Taylor, Udaya Udayaraj, Fergus J. Caskey, Kate Birnie, John Deanfield, Mark de Belder, Spiros Denaxas, Clive Weston, David Adlam, Dorothea Nitsch
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Acute myocardial infarction (AMI) causes significant mortality and morbidity in people with impaired kidney function. Previous observational research has demonstrated reduced use of invasive management strategies and inferior outc
Externí odkaz:
https://doaj.org/article/4b9f988d41e044aa860e1170f09d3a2c
Autor:
Jemima Scott, Lucy E. Selman, Fergus J. Caskey, Thomas Johnson, Yoav Ben-Shlomo, Pippa K. Bailey
Publikováno v:
International Journal of Qualitative Methods, Vol 22 (2023)
Background: People with chronic kidney disease (CKD) have significantly higher morbidity and mortality following myocardial infarction (MI) than the general population. Despite this, they are less likely to receive invasive management and guideline-d
Externí odkaz:
https://doaj.org/article/f0b1f819071c48f6ba5c0cd7f30a515e
Autor:
Jemima Scott, Fergus Caskey, Dorothea Nitsch, David Adlam, Clive Weston, Spiros Denaxas, John Deanfield, Mark De Belder, Michael Sweeting, Lucy Teece, Patrick Bidulka, Udaya Udayaraj
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Objectives Acute myocardial infarction (AMI) case ascertainment improves for the UK general population using linked health data sets. Because care pathways for people with chronic kidney disease (CKD) change based on disease severity, AMI case ascert
Externí odkaz:
https://doaj.org/article/a38336473fbb4fa0a7bf5a2b5cd42a83
Autor:
Jemima Scott, Tim Jones, Maria Theresa Redaniel, Margaret T. May, Yoav Ben-Shlomo, Fergus Caskey
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background The risk of acute kidney injury (AKI) attributable to renin angiotensin aldosterone (RAAS) inhibitors and diuretics remains unclear. Methods We conducted a prospective cohort study using the Clinical Practice Research Datalink (20
Externí odkaz:
https://doaj.org/article/d55811bd94c1431a9e2365e671cfac3a
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Objectives To determine the response process validity, feasibility of completion, acceptability and preferences for three patient-reported outcome measures that could be used in economic evaluation—the EQ-5D-5L, ICECAP-A and ICECAP-O—in people re
Externí odkaz:
https://doaj.org/article/274b179eb58a4e18982cc3a2a548cc84
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
BMJ Open
Mitchell, P M, Caskey, F J, Scott, J, Sanghera, S & Coast, J 2020, ' Response process validity of three patient reported outcome measures for people requiring kidney care : a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O ', BMJ Open, vol. 10, no. 5, pp. e034569 . https://doi.org/10.1136/bmjopen-2019-034569
BMJ Open
Mitchell, P M, Caskey, F J, Scott, J, Sanghera, S & Coast, J 2020, ' Response process validity of three patient reported outcome measures for people requiring kidney care : a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O ', BMJ Open, vol. 10, no. 5, pp. e034569 . https://doi.org/10.1136/bmjopen-2019-034569
ObjectivesTo determine the response process validity, feasibility of completion, acceptability and preferences for three patient-reported outcome measures that could be used in economic evaluation—the EQ-5D-5L, ICECAP-A and ICECAP-O—in people req
Autor:
Maria Theresa Redaniel, Fergus Caskey, Margaret T May, Timothy Jones, Jemima Scott, Yoav Ben-Shlomo
Publikováno v:
Scott, J, Jones, T, Redaniel, M T, May, M T, Ben-Shlomo, Y & Caskey, F 2019, ' Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors : A population based cohort study using the clinical practice research datalink ', BMC Nephrology, vol. 20, 481 (2019) . https://doi.org/10.1186/s12882-019-1633-2
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
Background The risk of acute kidney injury (AKI) attributable to renin angiotensin aldosterone (RAAS) inhibitors and diuretics remains unclear. Methods We conducted a prospective cohort study using the Clinical Practice Research Datalink (2008–2015
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1480fbc96f6a4b6a40810ce37f0fc72a
https://research-information.bris.ac.uk/en/publications/ab0aa324-0cb5-4e91-b405-2b00aa152299
https://research-information.bris.ac.uk/en/publications/ab0aa324-0cb5-4e91-b405-2b00aa152299
Publikováno v:
Clinical Kidney Journal
Background Intravenous drug use is associated with progressive kidney disease of several aetiologies. It is associated with behavioural and lifestyle characteristics that make the provision of renal replacement therapies (RRTs) challenging. We observ
Additional file 2. Excluding patients with strong indication for renin-angiotensin-aldosterone blockade (proteinuric chronic kidney disease and congestive cardiac failure). A sensitivity analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7b98276cfb90bcc3bffef406571b52